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Abstract
Background: Pedigree, demographic, square-root transformed maximum alcohol (SRMAXAPD)
and maximum cigarette (MAXCPD) consumption, and genome-wide scan data from the
Framingham Heart Study (FHS) were used to investigate genetic factors that may affect alcohol and
cigarette consumption in this population-based sample.
Results: A significant sister:sister correlation greater than spouse correlation was observed for
MAXCPD only. Single-point sib-pair regression analysis provided nominal evidence for linkage of
loci to both SRMAXAPD and MAXCPD consumption traits, with more significant evidence of
linkage to SRMAXAPD than to MAXCPD. One genomic region, chr9q21.11, exhibits significant
multi-point sib-pair regression to SRMAXAPD.
Conclusion: SRMAXAPD exhibits greater evidence for genetic linkage than does MAXCPD in the
FHS sample. Four regions of the genome exhibiting nominal evidence for linkage to SRMAXAPD in
the FHS sample correspond to regions of the genome previously identified as linked to alcoholism
or related traits in the family data set ascertained on individuals affected with alcohol dependence
known as COGA.
Background
Data from the ongoing NHLBI-supported Framingham
Heart Study (FHS) on cardiovascular disease (CVD) was
made available to Genetic Analysis Workshop 13
(GAW13). Two behaviors of general medical and psychi-
atric interest collected from this community-based sample
were included in the data, i.e., alcohol consumption and
cigarette consumption. Increased cigarette consumption
in the FHS sample is associated with the development of
CVD [1,2], but increased alcohol consumption in the FHS
is not, except in those aged 60–69 [3,4], although meta-
analyses of cohort and case-control samples, including the
FHS [3], identify a protective effect of moderate (1–2
drinks/day) alcohol consumption [5]. The consumption
of tobacco and alcohol confer significant risk for a variety
of medical disorders other than CVD, e.g., oral and pha-
ryngeal cancer [6] and for a common psychiatric comor-
bidity [7].
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The consumption of these two substances varies signifi-
cantly based on both sex and age and there has been a
long-term decline in the consumption of cigarettes in the
US in the latter half of the 20th century, due to health con-
cerns and restrictions placed on this behavior [8]. The
consumption of both substances is significantly correlated
in the American population and the prevalence of con-
sumption of alcohol and tobacco is increased by a factor
of two in consumers of either substance [9]. The genetic
influence on alcohol and tobacco dependence is signifi-
cantly correlated in men [10]. Measures of consumption
in multiple exams of the FHS provide an opportunity to
study the genetic correlation of alcohol and tobacco con-
sumption traits and search for susceptibility loci for these
traits in a community-based sample.
Results
Descriptive analysis of MAXAPD and MAXCPD
There were a total of 4692 individuals in the GAW13 FHS
sample, 2849 with a maximum alcohol consumption
(MAXAPD) measure and 2881 with a maximum cigarette
consumption (MAXCPD) measure. Descriptive statistics
of the MAXAPD and MAXCPD traits and a square root
transformation of MAXAPD, SRMAXAPD, are reported in
Table 1. The maximum alcohol consumption traits are
highly non-normal and the distribution remained highly
non-normal whether or not individuals with APD = 0 (N
= 346) were included. Individual outlier trait values > +4
standard deviations were changed to missing for analysis
(without outliers); the individuals whose values were con-
verted were predominantly male for all three traits but
were mostly (≥80%) from Cohort 1 for APD traits (N = 28
for MAXAPD, N = 7 for SRMAXAPD) and from Cohort 2
for MAXCPD (N  = 10). Removal of outliers brings
SRMAXAPD and MAXCPD traits much closer to normality
(Table 2). Because MAXAPD remains highly non-normal
even after positive outlier removal (Table 2), correlation
and linkage analysis results with MAXAPD are not
reported.
Correlations of alcohol and cigarette consumption traits
Familial correlations of relative and parental pairs (sex-
specific and non-sex-specific) without extreme positive
outliers for MAXCPD and SRMAXAPD are reported in
Table 3. For MAXCPD, only the correlation between sis-
ters is greater than that between parents, with or without
outliers. There are no familial correlations greater than the
spousal correlation for SRMAXAPD, with or without
outliers.
Sib-pair linkage analyses
In the single-point analysis, SRMAXAPD shows nominal
evidence for linkage at 17 markers on 10 chromosomes
with a p-value < 0.01 (Table 4). Chromosomes 7 and 9
have 3 markers each significant at a p-value < 0.01. In
addition, for this analysis treating sex as a covariate signif-
icantly predicted sib-pair trait covariance at p < 0.01, while
the regression analysis of age at which the maximum
amount of alcohol was consumed and cohort did not pro-
vide nominal evidence for linkage at the p < 0.05 level.
Multi-point linkage analysis with SRMAXAPD identified
chromosome 9 as the chromosome with the most
significant multi-point linkage result in the 10 chromo-
somes evaluated. Thirteen consecutive markers on chro-
mosome 9 showed evidence of linkage at p < 0.05, with
five of them showing significance at p < 0.01. The most
significant p-value observed on chromosome 9 was 3.77 ×
10-4 at marker c9g8 (Figure 1).
Table 1: Non-normality of MAXAPD, SRMAXAPD, and MAXCPD, with outliers.
Trait N Min Max Mean Median SD Kurtosis SE Skewness SE
MAXAPD 2849 0 624.00 23.34 11.00 35.80 57.88 0.09 5.39 0.05
SRMAXAP
D
2849 0 24.98 3.86 3.32 2.91 2.82 0.09 1.14 0.05
MAXCPD 2881 0 95.00 13.93 10.00 15.61 0.96 0.09 1.06 0.05
Table 2: Non-normality of MAXAPD, SRMAXAPD, and MAXCPD, without outliers.
Trait N Min Max Mean Median SD Kurtosis SE Skewness SE
MAXAPD 2821 0 166.00 21.15 11.00 26.25 5.64 0.09 2.14 0.05
SRMAXAP
D
2842 0 15.43 3.82 3.32 2.80 0.77 0.09 0.84 0.05
MAXCPD 2871 0 70.00 13.69 10.00 15.08 -0.03 0.09 0.88 0.05BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S101
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The single-point analysis for the trait for cigarette con-
sumption, MAXCPD, found nominal evidence for linkage
at nine markers on 7 chromosomes at p < 0.05 (Table 5).
The effects of the covariates cohort, sex, and age at MAX-
CPD on sib-pair trait covariance were inconsistent. There
was only one chromosome with more than one marker
exhibiting nominal evidence for linkage. Multi-point
results for MAXCPD were unremarkable.
Table 3: Significant familial correlations of SRMAXAPD and MAXCPD without outliers.
Correlation MAXCPD ± SE SRMAXAPD ± SE
father:son 0.058 0.041 0.133 0.041
mother:son 0.018 0.042 0.097 0.039
father:daughter 0.153 0.041 0.105 0.041
mother:daughter 0.141 0.041 0.163 0.039
brother:brother 0.179 0.045 0.150 0.046
sister:brother 0.130 0.034 0.164 0.032
sister:sister 0.268 0.046 0.186 0.045
parent:offspring 0.072 0.023 0.102 0.022
sibling:sibling 0.171 0.026 0.131 0.025
mother:father 0.199 0.044 0.310 0.042
Multi-point linkage analysis of SRMAXAPD (outliers removed) Figure 1
Multi-point linkage analysis of SRMAXAPD (outliers removed).BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S101
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Discussion
In the genome-wide search for linkage evidence to maxi-
mum alcohol consumption, we found a number (N = 17)
of marker loci that were nominally linked (p < 0.01) with
the maximum alcohol consumption traits, SRMAXAPD. A
broad region on chromosome 9 exhibited the most signif-
icant evidence for linkage, with the maximum linkage evi-
dence at ~66 cM (Table 4 and Figure 1). For the cigarette
consumption trait, MAXCPD, we observed fewer loci (N =
9) with evidence for nominally significant (p < 0.05) link-
age and no loci at p < 0.021. The low number of loci
exhibiting nominal evidence for linkage to MAXCPD
suggests that the MAXCPD trait, as investigated in this
linkage analysis, lacks power to detect the influence of
genetic susceptibility factors on maximum cigarette
consumption.
Empirical p-values for the significance of linkage analysis
results were not substantially different from asymptotic p-
values for either trait, suggesting that assumptions of the
SIBPAL regression model apply to the phenotypic and
genotypic data analyzed in this study. Only the regions of
maximum linkage to SRMAXAPD on chromosome 9 and
the single-point linkage analysis result to SRMAXAPD on
chromosome 17 at 89 cM provided statistical evidence for
linkage at p < 0.0007, a level considered "significant" by
Lander and Kruglyak [11]. Multiple testing corrections in
investigations of alcohol and cigarette consumption phe-
Table 4: Markers exhibiting evidence (p-value < 0.01) for linkage to SRMAXAPD.A
Loci Marker Pairs Regression Estimate SE p-Value
c1g27 D1S549 1455 1.55 0.54 0.0023
c4g3 D4S2633 1373 1.54 0.55 0.0025
c4g7 D4S3248 1432 1.47 0.57 0.0051
c6g10 D6S1053 1478 1.37 0.54 0.0054
c6g14 D6S1021 1428 1.42 0.57 0.0061
c7g10 D7S2204 1448 1.43 0.51 0.0027
c7g16 D7S1804 1426 1.34 0.52 0.0049
c7g22 D7S559 1382 1.63 0.52 0.0010
c9g8 D9S301 1410 1.75 0.53 0.0005
c9g9 D9S1122 1458 1.50 0.59 0.0056
c9g13 D9S910 1499 1.57 0.60 0.0044
c12g2 Unknown 1340 1.30 0.52 0.0061
c12g11 D12S1052 1458 1.35 0.56 0.0084
c15g7 D15S1507 1406 1.44 0.58 0.0064
c16g13 D16S539 1465 1.44 0.55 0.0046
c17g12 D17S1290 1485 1.63 0.50 0.0006
c22g4 D22S689 1470 1.39 0.55 0.0058
ALinkage analysis via regression of the mean corrected cross product of SRMAXAPD to allele IBD information with covariates sex, age at 
SRMAXAPD, and cohort.
Table 5: Markers exhibiting evidence (p-value < 0.05) for linkage to MAXCPD.A
Loci Marker Pairs Regression Estimate SE p-Value
c5g14 D5S1726 306 79.40 38.79 0.021
c6g1 Unknown 1425 43.24 23.82 0.035
c6g20 242zg51 1444 40.36 21.61 0.031
c8g3 D8S1130 1420 45.96 22.89 0.022
c9g18 308vb11 313 94.17 55.44 0.045
c15g9 D15S818 1103 50.77 28.19 0.036
c16g4 049xd21 1476 37.49 21.63 0.042
c20g9 321xd11 300 84.67 43.70 0.027
c20g10 D20S480 1412 41.11 23.86 0.043
ALinkage analysis via regression of the mean corrected cross product of MAXCPD to allele IBD information with covariates sex, age at MAXCPD, 
and cohort.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S101
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notypes performed independently, as in this study, would
need to consider the significant correlation between the
two behaviors [9].
Linkage studies of alcohol- and cigarette-related traits
have identified regions of the genome with more than
nominal evidence for linkage [12]. Regions of the genome
that have been identified as nominally linked to pheno-
types related to alcohol consumption include chromo-
some 1 (~170 cM) and chromosome 7 (~80–100 cM) for
alcohol dependence [13,14], chromosome 1 (~200–250
cM) and chromosome 15 (~70 cM) with a factor com-
posed of later age of onset of drinking and increased harm
avoidance [15], chromosome 4 (~120 cM) for alcohol
consumption [16], chromosome 1 (~100–150 cM) for
alcoholism or depression [17], chromosome 1 (~100–
150 cM) and chromosome 21 (~80 cM) for alcohol sensi-
tivity [18], all in the COGA sample [13], and chromosome
4 (~70 cM) and chromosome 11 (~0 cM) in the NIDDK/
NIAAA American Indian sample [19]. Regions identified
in this analysis of maximum alcohol consumption in the
Framingham sample that correspond to the regions iden-
tified in the literature include chromosomes 1 [15], 4
[18], 7 [16], and 15 [15]. Regions of the genome that have
been identified as nominally linked to phenotypes related
to cigarette consumption in other samples include chro-
mosome 1 (~0 cM), chromosome 2 (~90 cM), chromo-
some 14 (~95 cM) for ever-smoking in the COGA sample
[20], and chromosome 2 (~145 cM) and chromosome 10
(~120 cM) in the Christchurch sample [21]. There were no
regions of the genome in the Framingham sample with
nominal evidence of linkage to cigarette consumption
that overlapped regions identified in the COGA and
Christchurch samples exhibiting linkage to cigarette
related phenotypes. However, in the FHS sample, chro-
mosome 15 contains markers that exhibit nominal evi-
dence for linkage to SRMAXAPD (Table 4) and MAXCPD
(Table 5) at 60 cM and 72 cM, close to a region of chro-
mosome 15 in the COGA sample exhibiting suggestive
linkage to a factor composed of later age of onset of drink-
ing and increased harm avoidance [15].
Conclusions
We observed several marker loci with nominal evidence
for linkage to the square-root transformed maximum
alcohol consumption traits, SRMAXAPD, in the Framing-
ham Heart Study sample. Some of the regions of the
genome have been previously linked to alcoholism or
related traits in Caucasian samples based on different
ascertainment criteria.
Methods
Selection of consumption data
The traits of interest were defined as the maximum
reported number of grams of alcohol per day (MAXAPD),
and the maximum reported number of cigarettes smoked
per day (MAXCPD). Exams 1, 2, 4, and 7 from FHS Cohort
1 and exams 1, 2, 3, and 4 from FHS Cohort 2 were chosen
to assess MAXAPD and MAXCPD to utilize multiple
exams at the earliest age possible to obtain measurements.
Covariates of interest included cohort, age of maximum
consumption measure, and sex.
Analysis of phenotypic, pedigree, and genotypic data
GAW13 FHS data were imported into a Microsoft Access
database and exported in appropriate files for descriptive
statistical analysis in SPSS Advanced Statistics or Microsoft
Excel and familial correlation and linkage analysis in
S.A.G.E. [22]. Familial correlations and the asymptotic
standard errors were estimated using FCOR from S.A.G.E.
4.2. We used GENIBD from S.A.G.E. 4.2 to generate iden-
tity-by-descent (IBD) sharing distributions of the GAW13
data. Before running the GENIBD analysis, we used
MEGA2 [23] to convert the GAW13 data to the column-
delimited S.A.G.E. format.
SIBPAL from S.A.G.E. 4.2 was used to model the sib-pair
covariance of traits reported as a function of marker allele
identity-by-descent (IBD) sharing. Our analyses used esti-
mated IBD information from the GENIBD procedure
described above to perform single-point linkage analysis
in which the mean corrected cross product of the trait was
regressed onto the IBD information one trait at a time.
The single-point linkage analysis was carried out sepa-
rately for traits MAXAPD, SRMAXAPD, and MAXCPD,
treated as continuous variables. The covariates sex, age of
trait report, and cohort were included in the regression
models. SRMAXAPD single-point linkage analysis was
only performed without outliers. Empirical p-values were
obtained for single-point linkage analysis of MAXCPD
and SRMAXAPD to evaluate possible deviation from
asymptotic  p-values. Multi-point linkage analysis was
performed using IBD distributions at multiple markers for
MAXCPD and SRMAXAPD on those chromosomes
showing nominal evidence (p < 0.05 and p < 0.01, respec-
tively) for linkage at two or more consecutive loci.
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